Diamond-Blackfan Anemia vs Transient Erythroblastopenia of Childhood

Slides:



Advertisements
Similar presentations
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Advertisements

Heather D. Mannuel, MD, MBA March 12, 2008
1 Anemia of chronic disease = Anemia of chronic disorders (ACD)
Approach to Anemia - Summary
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
APLASTIC AND HYPOPLASTIC ANEMIAS
Normocytic Anemia Dr. Fatin Al-Sayes, MD, MSc, MRCPath Consultant Hematology / Assistant Professor King Abdulaziz University Hospital.
Alterations of Erythrocyte Function
Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 2 nd Year – Level 4 – AY Mr. Waggas Ela’as, M.Sc, MLT.
An Approach to Anemia.
MLAB Hematology Keri Brophy-Martinez
Aplastic Anemia Rakesh Biswas
Diamond Blackfan Anaemia Yvonne Harrington DBA conference 15 th November 2014.
LEUKEMIA—HEMATOLOGY {S1}
Tessa Bandhan. Question 1 A 3 year old girl known to have sickle cell disease (Hb SS) presents to the Emergency Room with a 2 day history of weakness.
Normocytic Normochromic Anemias
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
Chapter 17 Chronic Leukemias.
Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.
By Fatin Al-Sayes MD, MSc, FRCPath Consultant Hematology Assistant Professor.
By assistant lecture: Waleed fouad
Marrow Failure Kathryn Scharbach Marrow failure syndromes & diseases Multilineage Failure Fanconi anemia Fanconi anemia dyskeratosis congenita dyskeratosis.
Laboratory diagnosis of Anemia
HIV and haematology Mike Webb Division of Clinical Haematology 5 March 2011.
Pediatric Pathology. “Children are not merely little adults, and their diseases are not merely variants of adult diseases”
Aplastic anemia. Definition Panctopenia with hypocellularity A rare and serious condition, aplastic anemia can develop at any age, though it's most common.
1 Alterations of Hematologic Function in Children Chapter 28.
1 Approach to Anemia in Children Dr.Hekmati Moghaddam.
MLAB HEMATOLOGY KERI BROPHY-MARTINEZ Myelodysplastic Syndromes.
Alterations of Erythrocyte Function Chapter 26 Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
CLASSIFICATION OF ANEMIA
MLAB 1415: Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
1 CASE REPORT hematology Monika Csóka MD, PhD year old boy no abnormalities in previous anamnesis 2 weeks before viral infection (fever, coughing)
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
Parvovirus B19 Infections. Pathogenesis Autonomous parvoviruses are highly parasitic because of their molecular simplicity. Autonomous parvoviruses are.
APLASTIC ANEMIA Divisi Hemato-Onkologi Bagian Ilmu Kesehatan Anak Universitas Sumatera Utara.
Done by : Bara Shayib Supervised by : Dr. Abdullateef Alkhateeb.
Paige Myers & Mahek Shah.  Cancer is a disease in which the DNA of cells becomes damaged or changed and the affected cells do not respond to apoptosis.
CHAPTER 7 DISORDERS OF BLOOD CELLS & VESSELS. HEMATOPOIESIS Generation of blood cells Lymphoid progenitor cells = lymphocytes (WBCs) Myeloid progenitor.
APLASTIC AND HYPOPLASTIC ANEMIAS Waggas Elaas. APLASTIC ANEMIA Aplastic anemia is a severe, life threatening syndrome in which production of erythrocytes,
MLAB Hematology Keri Brophy-Martinez
Acquired Hemolytic Anemias
Anemia of chronic disease = Anemia of chronic disorders (ACD) 1.
Anemia of Chronic Disease
MLAB Hematology Keri Brophy-Martinez
Treatment of Aplastic Anemia
. Parvovirus B19 Yvonne Cossart, an Australian virologist working in London in the mid-1970s the name comes from parvum, the Latin word for small contains.
MLAB 1415-Hematology Keri Brophy-Martinez
Blood Biochemistry BCH 577
MLAB Hematology Keri Brophy-Martinez
Malignancies of hematopoietic cells. Leukemia
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
Megaloblastic anemias
September 12th, 2011 Good Morning.
November 18, 2010.
Anemia By: Dr Sunita Mittal.
MLAB 1415-Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Symptoms and Signs in Hematology/ 2013
Case Study ….
Anemia of chronic disease =Anemia of chronic disorders (ACD)
Congenital Macrocytic Anemia
Case Presentation Diagnostic Hematology
Male patient of 52 years old with a two-year history of fatigue and pruritus of his legs , headache . And visual disturbances . He smoked one pack of.
In the name of god.
Neoplastic disorder.
Sickle cell disease By Mayu & Jovany.
A negatively stained preparation of parvovirus seen by transmission electron microscope.
Presentation transcript:

Diamond-Blackfan Anemia vs Transient Erythroblastopenia of Childhood Samin Alavi, Associate professor, PCHD-RC, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Neonatal Hematology Congress, 22-24 Shahrivar 96, Tehran, Iran.

Diamond Blackfan Anemia Recognize the clinical, molecular, and laboratory manifestations of “Diamond-Blackfan Anemia ”

Diamond Blackfan Anemia DBA is a pure red cell aplasia that is usually recognized in early infancy, associated with a reduction in or an absence of erythroid precursors in bone marrow, variable congenital anomalies, and a predisposition to malignant disease. Diamond-Blackfan anemia red cells characteristically have increased ADA activity in 80-90 % of patients. In more than 90% of patients with DBA, the diagnosis is made before the age of 1 year, but in rare cases severe anemia may develop in utero (nonimmune hydrops fetalis) or later in life. The median age at diagnosis is 8 weeks of age. patients present in early childhood with profound macrocytic or normocytic anemia, reticulocytopenia, and a reduction or an absence of erythroid precursors in bone marrow.

The lack of red cell precursors can be mild to moderate or severe The lack of red cell precursors can be mild to moderate or severe. In this severe example, only a single late orthochromatic normoblast is present (arrow). All other cells are either myeloid elements or lymphocytes. It is usually the severe lack of late precursors than very early precursors.

3 diagnostic criteria + 1 major OR 2 minor Diamond-Blackfan anaemia (DBA) is an inherited disease characterized by pure erythroid aplasia that has been tagged as a “ribosomopathy” Non classic DBA: 3 diagnostic criteria + 1 major OR 2 minor 2 diagnostic criteria + 2 major OR 3 minor

Paucity of erythroid precursors in marrow Major supporting criteria: Diagnostic Criteria: Age < 1 yo Macrocytic anemia Reticulocytopenia Paucity of erythroid precursors in marrow Major supporting criteria: The presence of a gene mutation associated with DBA Positive family history Minor supporting criteria Elevated eADA activity Congenital anomalies Elevated Hemoglobin F No evidence of other inherited bone marrow failure syndrome probable diagnosis of Diamond-Blackfan anemia : Three diagnostic criteria and a positive family history Two diagnostic criteria and three minor criteria A positive family history and three minor criteria Non classical DBA is diagnosed when there is a DBA associated gene mutation but insufficient diagnostic criteria

DBA: Congenital Anomalies Are seen in at least 47% of all patients - 50% cranioorofacial (tow colored hair, blue sclerae, glaucoma, cleft palate) - 38% upper extremity (thumbs, may be subtle) 39% genitourinary 30% cardiac Over 20% with more than one anomaly Short stature and bony abnormalities common, and often overlooked!

e ADA activity ADA activity in patients with DBA was greater than that seen in: Cord blood Hemolytic anemia Acquired aplastic anemia Fanconi anemia, Acquired pure red-cell aplasia, Transient erythroblastopenia of childhood. Adenosine deaminase activity may be a unique marker for identifying DBA e ADA has a sensitivity of 84% and specificity 95%, 16% of patients with classical clinical DBA had a normal eADA Br J Haematol. 2013 Feb;160(4):547-54. 

DBA: Genetics Autosomal dominant, Autosomal recessive May be sporadic (2/3) or familial (1/3) Mutations/deletions in ribosomal proteins genes are observed in 70% of patients. RP S19 (DBA 1) in 25% of patients - RP L5, RP S10, RPL 11, RP L35a, RP S26, RP S24, RP S 17, RP S7, RP L19, RP L 26 25-40% of patients have unknown mutations Mutations in RP S19 is associated with a decrease in proliferation of progenitor cells but normal terminal erythroid differentiation, Mutations in RP L11 is associated with a decrease in progenitor cell proliferation and delayed erythroid differentiation with a marked increase in apoptosis.

Gene % of DBA Attributed to  Pathogenic Variants in This Gene RPL5 ~6.6% RPL11 ~4.8% RPL35A ~3% RPS10 ~2.6% RPS17 ~1% RPS19 ~25% RPS24 ~2% RPS26 ~6.4%

In some individuals with DBA , the anemia is transient; however, the macrocytosis and elevated ADA levels often persist. Spontaneous remission of anemia in DBA patients has been reported in 20-30% , even after years of steroid or transfusion dependence Thrombocytosis (platelet counts > 1 ,000,000 rarely) and decreased platelet counts have also been reported. WBCs are generally normal but in some cases leukopenia is present. In rare cases DBA progresses to the full clinical picture of severe aplastic anemia. Dyserythropoietic morphology, including ringed sideroblasts, have rarely been reported.

DBA: Treatment of anemia Prednisone: 2 mg/kg for up to 8-12 weeks before diagnosis of failure ,Taper to minimum dose to maintain Hgb > 9 g/dl 60-70 % steroid responsive Glucocorticoid treatment increases the erythropoietin sensitivity of both normal and DBA erythroid progenitors, but DBA erythropoietic differentiation and maturation remains suboptimal For steroid-refractory patients or those requiring high doses of steroids, consider chronic red cell transfusions Metoclopramide, CSA, IL-3 , Androgens, Valproic acid Leucine ( mTor activator , induces protein metabolism and synthesis) ….

Pure red cell aplasia is morphologically characterized by severe lack of erythroid precursors , whereas myeloid precursors and megakaryocytic elements are unaffected and are present in normal numbers.

DBA Outcomes Remission of anemia : 20% by age 25 No genetic or clinical feature predicts of remission. HSCT for transfusion-dependent patients, particularly those who are alloimmunized or have OTHER cytopenias (neutropenia) is recommended. HSCT Does not cure solid tumor risk The sibling donor needs careful evaluation for DBA

Diamond Blackfan Anemia…. Malignancy 30 Cases* Reported in the Literature AML/MDS 15 ALL 1 Osteosarcoma 6 Hodgkin disease/NHL 3 Breast carcinoma 2 Hepatocellular carcinoma 2 GI carcinoma 2 Melanoma 1 Malignant fibrous histiocytoma 1 Soft tissue sarcoma 1 Non-Hodgkin Lymphoma 1 From Alter, BP. In Shimamura and Alter, Blood Reviews, 2010

Differential Diagnosis of Childhood Pure Red Cell Aplasia Congenital: Pearson syndrome, SDS, FA, DC, CHH Acquired: Immune pure red cell aplasia Transient erythroblastopenia of childhood (TEC) Infection associated – parvovirus Collagen vascular disease/autoimmune associated Thymoma Pregnancy Severe renal failure, nutritional Drugs or Toxins

Transient Erythroblastopenia of Childhood (TEC) Although it has been diagnosed in children as young as 1 month old, it usually presents in children 6 months – 6 years old, particularly between the ages of 1 and 4 years. It is more common in males than in females. The incidence of TEC is difficult to estimate since it is likely that most cases are subclinical,

Transient Erythroblastopenia of Childhood (TEC) The etiology for suppression of erythropoesis in TEC remains unknown, environmental exposures, viral illness, and genetic predisposition have been proposed. While parvovirus B19 is known to cause red cell aplasia in children with hemolytic anemia, no association has been found with TEC in multiple studies. Multiple case series have suggested that there is an association with an antecedent viral URI or gastroenteritis 2-3 months prior to symptom onset, although there is no seasonal clustering. No specific mutation or affected gene was identified in TEC.

Transient Erythroblastopenia of Childhood (TEC) Typically self limited – close supportive care Transfusion if necessary in Hgb < 5 with reticulocytopenia Follow-up to resolution Findings on CBC:​ Normochromic/ Normocytic anemia (Absence of macrocytosis) During the recovery phase, RBCs become transiently macrocytic ​Reticulocytopenia (<3%) and then reticulocytosis in recovery Normal WBC Mild neutropenia in 20-50% ​Normal platelets or thrombocytopenia

Diamond Blackfan Anemia vs Transient Erythroblastopenia of Childhood DBA TEC History: Inherited Acquired Physical Anomalies: 50% none Laboratory: Hb : 1.2-10.0 gr 2.4-10.6 gr ANC < 1000/µl 20% 10% Plts > 400,000 /µl 20% 50% plts < 100,000 /µl 10% 5%

DBA vs TEC E ADA increased: 85- 90% 0% MCV increased: DBA TEC E ADA increased: 85- 90% 0% MCV increased: At diagnosis 80% 20% During recovery 100% 90% In remission 100% 0% Hb F increased At diagnosis 100% 25% During recovery 100% 100% In remission 85% 0%

Aplastic Crisis in Hemolytic Anemia May resemble TEC or DBA, if no prior diagnosis of a hemolytic anemia Acquired pure red cell aplasia:​ TEC Infectious (parvovirus, hepatitides, EBV, HIV, HHV6, echovirus) ​Drug associated (AEDs, sulfonamides, isoniazid, azathioprine, procainamide) Rheumatologic (SLE, JIA) Autoimmune Thymoma, lymphoid malignancies